Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of Neffy and intramuscular epinephrine for allergic reactions after oral food challenges or allergen immunother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intramuscular Adrenalin (epinephrine)
  • NEFFY (epinephrine)

Snippet

Sponsor: ARS Pharmaceuticals, Inc. | Conditions: Allergic Reactions | Phase 4 | Status: RECRUITING